Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Galantamine/memantine

Weight loss (first report with memantine) in an elderly patient receiving dopamine receptor agonists: case report

    • 8 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Gallini A, Sommet A, Salandini A-M, Veyssière P, Montastruc J-L.Weight-loss associated with anti-dementia drugs in a patient with Parkinson’s disease. Movement Disorders 22: 1980-1981, No. 13, 15 Oct 2007 - France

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Galantamine/memantine. React. Wkly. 1179, 16 (2007). https://doi.org/10.2165/00128415-200711790-00047

    Download citation

    Keywords

    • Body Weight
    • Dopamine
    • Dementia
    • Weight Gain
    • Levodopa